Purpose. This paper aims to evaluate the antimicrobial resistance of Esherichia coli isolates from children under 5 years old, with and without diarrhoea, who were hospital outpatients in Culiacan, Sinaloa, Mexico. It also looks at the antimicrobial activity of fruit extracts against selected multidrug-resistant (MDR) E. coli strains.
INTRODUCTION
Diarrhoeal diseases are a public health concern worldwide and are the second leading cause of death in children under 5 years old, with 760 000 deaths each year [1] . In Mexico, gastrointestinal infections, caused by bacteria or parasites, are the second leading cause of death in preschool children and, although the mortality rate has decreased in recent years, morbidity remains high [2] . Escherichia coli is the most common bacterial aetiologic agent of mild to severe diarrhoea and it is one of the most important targets for antimicrobial therapy [3, 4] . Thus, E. coli has been exposed to continuous selective pressure, showing excellent adaptability, which corresponds with the evolutionary appearance of resistant strains [5] [6] [7] . The number of antimicrobial-resistant E. coli strains, particularly to thirdgeneration cephalosporins and fluoroquinolones, has increased worldwide [8] [9] [10] [11] . In Latin America, the resistance prevalence is high [6, 10, 12] . During the period [2004] [2005] [2006] [2007] [2008] [2009] [2010] in Mexico, up to 68.3 % of E. coli isolates were resistant to third-generation cephalosporins [7] . Also, the emergence of multidrug-resistant (MDR) strains is a major issue in the therapeutic management of patients with such infections, who are at severe risk of death [7] .
In the context of the multidrug resistance phenomenon, it is vitally important to find alternative therapeutic treatments. In this regard, medicinal plants have traditionally been an effective option [13, 14] . Mexico is rich in flora biodiversity [15] and many of its native plants have been used to treat infectious diseases associated with diarrhoea. Our laboratory has reported the antibacterial activity of extracts/fractions of the fruits of ayale (Crescentia alata), arrayan (Psidium sartorianum) and uvalama (Vitex mollis) [16, 17] , as well as the synergistic effect of extracts of Echeveria subrigida and commercial antibiotics against MDR strains [18] . To date, studies of antibiotic-resistant bacteria in children under 5 years old from Mexico are scarce. This study analysed the activity of 19 antimicrobials in E. coli strains isolated from children with and without diarrhoea in order to identify the resistance patterns. Additionally, we evaluated extracts/fractions of fruits native to Mexico as potential complementary or alternative treatments for MDR strains.
METHODS
E. coli isolates A total of 205 E. coli isolates from stool samples from 94 children were analysed: 101 isolates from 46 children with diarrhoea and 104 isolates from 48 children without diarrhoea; the latter served as the control group. The qualitycontrol strains for the study were Pseudomonas aeruginosa ATCC 27853 and E. coli ATCC 25922, as well as the clinical E. coli isolates used in previous reports (A011, A055 and A019) [16, 19] . The samples were collected from children under 5 years old who were outpatients from two hospitals (Civil Hospital of Culiacan and Pediatric Hospital of Sinaloa 'Dr Rigoberto Aguilar Pico') in the city of Culiacan, Sinaloa, Mexico, during the autumn/winter of 2003/04. Both hospitals are government-run, inexpensive and high-specialty. They receive patients from throughout the state of Sinaloa. Stool samples were collected using a rectal swab on Cary Blair medium (Oxoid) and transported to the laboratory. Subsequently, stools were plated on MacConkey agar (Becton Dickinson) and typical E. coli colonies were identified using the automated VITEK system (bioM erieux) employing Gram-negative identification (GNI) and Gram-negative identification plus (GNI+) cards (bioM erieux). The identified E. coli strains were cultured in brain heart infusion (BHI) broth (Becton Dickinson) with glycerol (15 % v/v) and stored at À70 C until use. [20] ; Sensi-Discs were from Oxoid. The undersides of the Petri plates were illuminated and the diameters of the inhibition halos were measured by using a Vernier ruler. All assays were carried out in duplicate. Antibiotic susceptibility was interpreted according to CLSI guidelines. The antimicrobial gentamicin (Sigma-Aldrich) and the strains E. coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as controls. The prevalence of bacterial MDR was determined according to Işeri et al. [21] and a strain was considered multidrug resistant if it was not susceptible to at least three antibiotics.
Preparation of fruit extracts
The fruits of arrayan (Psidium sartorianum), ayale (Crescentia alata) and uvalama (Vitex mollis) were collected from different valley regions in Culiacan, Sinaloa, Mexico. Dr Rito Vega-Aviña, a professor at the Agronomy Faculty of the Autonomous University of Sinaloa (UAS), identified the plant materials. After collection, fruits were freeze-dried, milled, passed through a no. 40 mesh and stored at À20 C until solvent extraction. Independently, each fruit meal (200 g) was thrice extracted with methanol (1 : 5 p/v), the solvent changed every day and the 3-day recovered solvent was vacuum concentrated to obtain the methanol extract (ME). The ME was successively fractionated (1 : 1 v/v) with hexane, chloroform, ethyl acetate and water. Organic fractions were concentrated under vacuum (40 C) to obtain the hexane (HF), chloroform (CF) and ethyl acetate (EAF) fractions of each fruit [22] . Used solvents were of reagent grade (J. T. Baker). The antibacterial activity against MDR isolates was only evaluated for those extracts/fractions with good antibacterial activity [16, 19] : the HF of ayale, the ME and HF of arrayan, and the CF and EAF of uvalama.
Evaluation of minimal inhibitory (MIC) and minimal bactericide (MBC) concentrations
Considering the bacterial resistance patterns registered in this study, a representative number of bacteria was tested for bacterial sensitivity to the plant extracts/fractions. The employed criteria were to select resistant strains to the highest number of individual antibiotics and families of antibiotics, including the same number of strains with similar resistance profiles and origin (children with and without diarrhoea). The MIC values were determined using the broth microdilution method according to CLSI guidelines [20] . Bacteria were incubated at 37 C for 18-20 h; an aliquot of culture was suspended in saline solution (0.85 % p/ v), adjusting the turbidity to 0.5 McFarland, and later diluted to 10 6 c.f.u. ml À1 in Mueller Hinton broth (Becton Dickinson). Utilizing 96-well plates, 50 µl of the adjusted culture was added to each well containing 50 µl of fruit extract at different concentrations; the negative control was inoculum without fruit extract, whereas the antimicrobial gentamicin (0.125-16 µg ml
À1
) was used as positive control. The microplates were incubated (20 h at 37 C) and the MIC value was determined by visual examination; an absence of turbidity or button of growth at the bottom of the well was defined as growth inhibition. To determine the MBC value, samples of wells with inhibited growth were plated on MacConkey agar. The plates were incubated (18-20 h at 37 C) and the MBC value corresponded to the well with the minimum extract concentration that prevented bacterial growth. The evaluated fruit extract concentrations were defined based on previous results [16, 19] . The arrayan ME, uvalama CF and uvalama EAF were evaluated in the 0.5-32 mg ml À1 concentration range, whereas ayale HF and arrayan HF were from 0.25 mg ml À1 to 20 mg ml À1 . All assays were carried out in triplicate.
Statistical analysis
The software Stata Intercooled version 14 was used for data analysis. The relationship between observed resistance and clinical status of the child was established using Pearson's chi-squared test, and the association between resistance patterns was determined by using Fisher's exact test. A value of P<0.05 was considered statistically significant.
RESULTS
A total of 205 E. coli isolates of stool samples were collected from 94 children under 5 years old who were outpatients from two hospitals in the city of Culiacan, Sinaloa, Mexico, during the autumn/winter of 2003/04. One hundred and one isolates were from 46 children with diarrhoea and 104 isolates from 48 children without diarrhoea; the latter served as the control group.
Antimicrobial susceptibility of the E. coli hospital isolates
The antimicrobial susceptibility evaluation showed that 196 (95.6 %) of the 205 analysed isolates were resistant to at least one of the 19 antimicrobials tested. Global analysis of data did not show significant differences (P=0.268) between the number of resistant isolates in children with diarrhoea (95, 94.1 %) and the control group without diarrhoea (101, 97.1 %). Of the 19 antimicrobials, carbenicillin (CAR) resistance was associated with a large number of strains (191, 93.2 %). Most of the bacterial isolates showed high frequencies of resistance (29.3-53.7 %) to different members of the family of b-lactams (CXM, AMP, PRL and TIM). The isolates also showed resistance to SXT (35.1 %) and NA (14.6 %). On the other hand, 100 % of the strains were susceptible to AK, F and MEM. The association between the E. coli susceptibility or resistance to antibiotics and the presence or absence of diarrhoea showed no significant difference among the E. coli strains except for CAR (Table 1) .
Isolates with intermediate resistance (IR) are defined as those isolates with antimicrobial agent MICs that approach usually attainable blood and tissue levels and for which response rates may be lower than for susceptible isolates [23] . The IR of E. coli isolates was registered mainly to blactams, with highest frequencies of resistance for CXM (36.1 %) and TIM (19.5 %). However, a higher number of E. coli strains (84.4 %) presented IR to TOB but were sensitive to other aminoglycosides. The statistical analysis showed significant differences between the IR of E. coli isolates from children with and without diarrhoea for CAR, SXT and CIP (Table 1) . Some strains showed a low frequency of resistance to some antimicrobials, but the number of resistant strains was significantly increased by including data of IR. This phenomenon was most evident with TOB, increasing the potential resistant strains from 2.9 to 87.3 %. Similar patterns, but with lower frequencies, were identified with CXM (53.7-89.8 %) and TIM (29.3-48.8 %) ( Table 1) .
Considering the E. coli resistance per family of antimicrobials, the highest frequency was for the b-lactams (95.6 %), followed by sulfonamides (35.1 %), quinolones (15.1 %) and aminoglycosides (5.4 %) (Table S1 , available in the online Supplementary Material). Analysing the activity of each blactam, variable resistance percentages ranging from 29.3 to 93.2 % were identified for carboxypenicillins, second-generation cephalosporins, penicillins, ureidopenicillins and carboxypenicillin with inhibitors of b-lactamases (ticarcillin/ clavulanic acid); whereas 4.9 % was registered for carbapenems and first-, second-, third-and fourth-generation cephalosporins (Table S2) .
Multiple resistance to antimicrobials
Only nine (4.4 %) of the 205 studied strains were susceptible to all antimicrobial families tested. With regards to resistant strains, 47 (22.9 %) were resistant to a single antimicrobial and 92 (44.9 %) to at least three antimicrobials of the four families of antibiotics tested. Considering the antibiotic families, six different patterns of multiresistance were identified; the combination of b-lactams and sulfonamides (20.4 %) was the most frequent, but it was not associated with the origin of the strains (Table 2) . When strain resistance was classified by individual antibiotics, 44 patterns of multiresistance were formed, and the individual frequency was lower than 8 %; in particular, many E coli isolates (48, 23.4 %) were resistant only to CAR and CXM, although this group of strains was not multiresistant. All multiresistance patterns included at least one b-lactam antibiotic, and most of them were sulfonamides and quinolones. Some of the resistance patterns involving four to six antimicrobials were associated with children with diarrhoea but with very low frequencies (Table S3) .
Antimicrobial activity of the fruit extracts E. coli strains selected from children with (14) and without (12) diarrhoea, resistant to at least two families of antibiotics, were exposed to fruit extracts/fractions (Table 3 ). The control antibiotic gentamicin inhibited the growth of all control strains with an MIC value of 1 µg ml À1 and only five (19.2 %) multiresistant strains were not inhibited up to the maximum concentration tested (16 µg ml À1 ).
Analysing the activity of the fruits, all the evaluated fractions inhibited the growth of MDR isolates of E. coli except for arrayan ME, which was inactive against three MDR isolates (C14-4, C8-3 and C15-5). Specifically, the arrayan HF showed the highest activity (MIC=0.25 mg ml
À1
) of all fruits in two of the MDR isolates (M14-1 and M15-4); however, the same fraction showed the lowest activity (MIC=20 mg ml À1 ) in six (23.1 %) isolates. The uvalama EAF showed very good activity, inhibiting the growth of nine (34.6 %) MDR isolates with MIC=1 mg ml
, whereas the uvalama CF had a MIC of 2 mg ml À1 for 10 (38.4 %) isolates. On the other hand, the ayale HF showed a MIC=3 mg ml À1 for 50 % of the tested bacteria (13) . Of the evaluated fruit extracts/fractions, 42.3 % of the isolates showed MIC values lower than or equal to 1 mg ml À1 (Table 4) .
MBC values were obtained for most (80 %) of the strains treated with arrayan ME (8-32 mg ml
) and about 53.3 % of the strains treated with ayale HF (3-10 mg ml À1 ); whereas for arrayan HF, they were obtained only for 36.6 % of the strains tested (3-10 mg ml À1 ). Remarkably, MBC values for the uvalama fractions (CF and EAF) were determined for all the isolates (MBC=2-16 mg ml
). For most MDR isolates with MBC, these values were different to the MIC values and for most strains MBC!2 MIC (Table 4) .
DISCUSSION
In the present study, E. coli strains isolated from faeces of children under 5 years old with and without diarrhoea showed resistance to commercial antibiotics (Tables 1 and  S3 ). The resistance prevalence for the E. coli isolates was high (95.6 %) and similar (72-94 %) to that reported in other regions of the world [8] [9] [10] [11] . Interestingly, MEM, CRO, CAZ, CN, F and FEP were highly effective against E. coli isolates from Culiacan, Sinaloa, showing low prevalence resistance values (0-0.5 %; Table 1) , whereas E. coli isolates from oriental countries were highly resistant to some of these antibiotics: CRO (42.9 %), CAZ (30.4-62.8 %), CN (28.6-33.3 %) and FEP (100 %) [4, 24, 25] . 
A, aminoglycosides; B, b-lactams; Q, quinolones; F, nitrofurans; S, sulfonamides. ‡The total number of resistant isolates obtained from children with diarrhoea was 101. §The total number of resistant isolates obtained from those without diarrhoea was 104.
*Statistically significant, P<0.05. Data of children with and without diarrhoea, corresponding to the same category, R or IR, and on the same row are compared. The * symbol is added to the highest numeric value. *The total number of resistant isolates obtained from children with diarrhoea was 101. †The total number of resistant isolates obtained from those without diarrhoea was 104. ‡The non-MDR group includes the E. coli strains susceptible to all antibiotics and those resistant to no more than two antibiotics. In Latin American countries, the prevalence of E. coli isolates resistant to commercial antibiotics shows high variability, with the highest values for AMP (30.2-70 %), SXT (30.9-61.7 %), tetracycline (28-42.8 %) and some cephalosporins (15-65 %); our strains showed the highest resistance values to these antibiotics. Additionally, the highest susceptibility of our E. coli isolates (Table 1 ) was also similar: FEP (100 %), CAZ (97.7-100 %), AK (100 %), F (90.1 %), CRO (100 %), MEM (97.5%) and CN (89.7-100 %) [3, 6, 12] . These data suggest that AK, F, CRO and MEM are better antibiotic treatments for E. coli-infected children under 5 years old than those including AMP and SXT or CAR and CXM. The high resistance profile of the E. coli isolates against some antimicrobials could be due to the location of the study, the population income in the region and natural selective pressure. Other factors include the transmission of resistant strains among persons, the consumption of meat from animals treated with antibiotics, as well as the easy access to first-line antibiotics and subsequent self-medication. On the other hand, the carbapenems (e.g. MEM), which are last-line antibiotics, are expensive and mostly administered to patients in a critical condition as a last resort [5, 7, 26] .
Reports about the antibiotic susceptibility of E. coli isolates from faeces of children in Mexico are scarce, and a 90 % prevalence resistance for AMP has been reported [26] . On CN, gentamicin; ME, methanol extract; HF, hexane fraction; CF, chloroform fraction; EAF, ethyl acetate fraction; NG, growth was not observed; -, no antibacterial activity was registered up to the highest concentration evaluated (32 mg ml À1 for the ME of arrayan, and CF and EAF of uvalama; and 20 mg ml À1 HF of ayale and arrayan).
Uribe
the other hand, different E. coli pathotypes isolated from patients, mostly older than 20 years of age (65 %), with diarrhoea or gastroenteritis, were susceptible to CIP (50-100 %), SXT (16.6-50 %) and AMP (16.6-29.6 %) [27] . In general, previous studies of bacterial antibiotic susceptibility in Mexico are focused on nosocomial infections [28, 29] . However, in spite of differences in the sample origin and of the wide prevalence variation, our results were similar to those for the antibiotics of high prevalence resistance: CXM (43.2-63.9 %), AMP (86.6-100 %) and SXT (39.1-70.1 %), whereas the lowest values of resistance were for MEM (0-5.6 %) and AK (0.4-8.8 %). In this respect, our strains were susceptible to MEM and AK (Table 1) . Moreover, patterns registered for CIP (57.9-86.1 %) and CRO (41.7-63.3 %) have shown the highest prevalence resistance [30] [31] [32] [33] , but our strains showed low prevalence resistance for CIP (6.8 %) and susceptibility to CRO (Table 1) . Contrasting the frequencies of susceptibility and resistance of E. coli isolates from different geographical regions to commercial antibiotics, it can be deduced that similar management of some antimicrobials from various regions resulted in similar resistance patterns, whereas other antibiotics show regionspecific use, resulting in distinctive patterns [34] . Thus, similar studies are required to define the criteria for the correct selection of antibiotic treatment. In addition, studies to determine the frequency of MDR bacteria in the community are required because apparently healthy persons are carriers, and they could be disseminating such strains and generating a public health problem.
In our study, the resistance prevalence order per antibiotic family was b-lactams>sulfonamides>quinolones>aminogly-cosides (Tables 1 and S1 ). In contrast, when considering individual b-lactams, the E. coli isolates showed the highest prevalence resistance to carboxypenicillins, second-generation cephalosporins and penicillins (Table S2) . This pattern was similar to those in other studies reporting the lower efficiency of first-and second-generation cephalosporins and penicillins [33, 35] . It also should be noted that ticarcillin/ clavulanic acid (carboxypenicillin with a b-lactamase inhibitor) resulted in a 64 % reduction of the resistant strains (Table 1) . Extended-spectrum b-lactamase (ESBLs) can produce resistance to penicillins and to first-, second-and third-generation cephalosporins. ESBLs do not induce resistance to carbapenems (e.g. MEM), and strains with these enzymes are usually treated with b-lactamase inhibitors such as clavulanic acid [36] . Our results suggested that this could be the main mechanism of resistance among the E. coli isolates obtained from children in Culiacan, Sinaloa, Mexico. The presence of these enzymes in the E. coli isolates from Mexico has increased over the years, and our country shows one of the highest rates of E. coli resistance in Latin America [36] . Thus, future studies should investigate the presence of b-lactamase genes in our E. coli isolates.
Several E. coli isolates showed intermediate resistance to different antimicrobials, and some of the obtained percentages were higher than the values obtained in the resistant strains ( [4, 24] . These values are indicators of the emergence of strains capable of diminishing the effect of first-line antimicrobials, and they are a step away from becoming resistant strains. Consequently, it is important that they are identified in regional clinics. Moreover, these strains could be representative of the bacterial communities circulating among human populations in different regions [12] .
Considering the multiresistant E. coli isolates, the percentages of strains resistant to at least three, five and six antibiotics were 44.8, 32.7 and 20.4 %, respectively (Table S3) . These results partially agree with previous studies reporting frequencies of multiresistance to at least three antimicrobials from 33 to 63.3 % [8, 10, 11, 21] . The patterns of bacterial multiresistance found in our study are similar to those reported in Brazil, where the highest frequency (21.7 %) was for the pattern ampicillin/cephalothin/sulfonamide, which was also the most frequent pattern in our research (b-lactams and sulfonamides). Moreover, as in our study, they report all multiresistance patterns with frequencies lower than 7 % and all including at least one b-lactam (Tables 2  and S3 ) [10] . A high frequency of multiresistance for b-lactams with sulfonamides is also reported in Iran and Vietnam [8, 24] , demonstrating that improper use of these antibacterial agents throughout the world is contributing to the high bacterial resistance, probably associated with a selective positive pressure.
Our results showed that resistant and MDR bacteria were found in children under 5 years old independently of the symptoms of diarrhoea (Table 1) . Previous studies report similar observations, suggesting that the horizontal transference of genes between diarrheagenic and commensal E. coli strains increases the number of resistant bacteria [6, 12, 24] . Thus, it is important to study the evolution of the resistance profile of both diarrheagenic and commensal strains to control their populations and to develop effective treatments.
This study shows the high prevalence of resistant and MDR E. coli strains in Culiacan, Sinaloa, M exico. This phenomenon hinders the proper treatment of infections and establishes the need for therapeutic alternatives. Thus, one of the focuses of our research group is the use of natural plant products as alternative treatments for infectious diseases. This strategy considers the high floristic diversity of Mexico and the ethnopharmacological knowledge of Mexicans to treat different diseases such as those that induce diarrhoea [13, 14] . Our previous studies have demonstrated that extracts of fruit native to Sinaloa are active against Gram-positive and Gram-negative bacteria that have been related to gastrointestinal infections [16, 17, 19] . Also, we have established the synergistic effect of plant extracts and commercial antibiotics against MDR bacteria [18] . The resistance profile to CN of the chosen MDR strains for the assays with the plant extracts agreed with both the KirbyBauer and broth microdilution methods, as well as with the values established by the CLSI for the control strain E. coli ATCC 25922 [23] (Tables 3 and 4 ). Compared to the MIC values from our previous studies against the clinical isolates used as control strains [16, 19] , the values in this study showed a slightly acceptable variation. In general, the antibacterial activity of the plant extracts/fractions, in decreasing order, was uvalama EAF>arrayan HF>uvalama CF>ayale HF>arrayan ME. Our results highlighted the good activity (MIC 1 mg ml À1 ) [37] of the uvalama EAF and arrayan HF against 34.6 and 26.9 % of the MDR E. coli isolates, respectively. On the other hand, the uvalama CF showed good activity (MIC=1 mg ml
À1
) against only one bacterial isolate (Table 4) . Although these results were similar to those obtained in our previous studies, the MIC values obtained were from two to four times higher but with some slightly lower values with the ayale HF [16, 19] . Remarkably, we found MBC values below 20 mg ml À1 for most of the MDR strains (Table 4) . However, differences were determined for the control strains; MBC values below 20 mg ml À1 were previously obtained against these strains for the arrayan HF and ayale HF, but they were not obtained in this study [19] . Variations in the MIC and MBC values with those previously reported could be associated with differences in the composition of the evaluated extracts, which are affected by diverse factors (e.g. geography, environment, season) [38] . Considering the 97 MBC values, bactericide activity (MIC=MBC) was found for 34 % of the MDR isolates, highlighting the effects of the uvalama EAF and ayale HF. However, bacteriostatic agents could be very important in the elimination of bacterial pathogens through enhancing the immune response [39] . Recently, our research group reported the synergism of the ME of Echeveria subrigida with commercial antibiotics against MDR E. coli isolates; the best activity was in combination with NAL and AMP. Such findings suggest that plant extracts combined with commercial antibiotics could be a good strategy to control the MDR bacteria circulating in our community [18] .
Altogether, our results show for the first time the presence of multiresistant E. coli isolates circulating in children under 5 years old, including those who are apparently healthy, from Culiacan, Sinaloa, Mexico. The observed results could probably be associated with improper use of antibiotics, the horizontal transference of genes and the consumption of products contaminated with antibiotics, among other factors. Thus, the selection of commercial antibiotics for the treatment of infections by these bacteria is a challenge. In this regard, our results also showed the potential of extracts and fractions of plants native to Sinaloa as alternative or complementary treatments for such infections, contributing to the control of the circulating multiresistant E. coli strains.
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